KR20220076562A - Manufacturing method of functional drink for enhancing immunity - Google Patents
Manufacturing method of functional drink for enhancing immunity Download PDFInfo
- Publication number
- KR20220076562A KR20220076562A KR1020200164287A KR20200164287A KR20220076562A KR 20220076562 A KR20220076562 A KR 20220076562A KR 1020200164287 A KR1020200164287 A KR 1020200164287A KR 20200164287 A KR20200164287 A KR 20200164287A KR 20220076562 A KR20220076562 A KR 20220076562A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- extract
- raw material
- heating
- material solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036039 immunity Effects 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 94
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 94
- 235000008434 ginseng Nutrition 0.000 claims abstract description 94
- 239000002994 raw material Substances 0.000 claims abstract description 59
- 241001499808 Allium atrorubens Species 0.000 claims abstract description 44
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000011593 sulfur Substances 0.000 claims abstract description 37
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 37
- 239000007788 liquid Substances 0.000 claims abstract description 34
- 240000002234 Allium sativum Species 0.000 claims abstract description 32
- 235000004611 garlic Nutrition 0.000 claims abstract description 32
- 235000020510 functional beverage Nutrition 0.000 claims abstract description 16
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract 6
- 240000004371 Panax ginseng Species 0.000 claims description 93
- 239000000284 extract Substances 0.000 claims description 37
- 238000010438 heat treatment Methods 0.000 claims description 32
- 229940072113 onion extract Drugs 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 27
- 150000003839 salts Chemical class 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 25
- 235000012907 honey Nutrition 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 17
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 17
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 17
- 235000017803 cinnamon Nutrition 0.000 claims description 17
- 229940010454 licorice Drugs 0.000 claims description 17
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 16
- 244000163122 Curcuma domestica Species 0.000 claims description 15
- 235000003373 curcuma longa Nutrition 0.000 claims description 15
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 14
- 235000013976 turmeric Nutrition 0.000 claims description 14
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 13
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 12
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 12
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 12
- 239000011425 bamboo Substances 0.000 claims description 12
- 239000001702 nutmeg Substances 0.000 claims description 12
- 241001061264 Astragalus Species 0.000 claims description 9
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 9
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 9
- 235000006533 astragalus Nutrition 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 210000004233 talus Anatomy 0.000 claims description 9
- 241000361919 Metaphire sieboldi Species 0.000 claims description 6
- 244000270834 Myristica fragrans Species 0.000 claims description 5
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 3
- 240000007890 Leonurus cardiaca Species 0.000 claims description 3
- 244000082204 Phyllostachys viridis Species 0.000 claims 2
- 230000000840 anti-viral effect Effects 0.000 abstract description 6
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 27
- 241001247821 Ziziphus Species 0.000 description 26
- 235000002639 sodium chloride Nutrition 0.000 description 24
- 230000000694 effects Effects 0.000 description 19
- 230000009471 action Effects 0.000 description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000002689 soil Substances 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 241001330002 Bambuseae Species 0.000 description 10
- 229930182490 saponin Natural products 0.000 description 9
- 150000007949 saponins Chemical class 0.000 description 9
- 235000017709 saponins Nutrition 0.000 description 9
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
- 230000001093 anti-cancer Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000004720 fertilization Effects 0.000 description 8
- 239000003337 fertilizer Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 241000498779 Myristica Species 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000015788 innate immune response Effects 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 241000207925 Leonurus Species 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 229930182494 ginsenoside Natural products 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 206010003210 Arteriosclerosis Diseases 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 208000011775 arteriosclerosis disease Diseases 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 238000001784 detoxification Methods 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000002075 main ingredient Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000001256 tonic effect Effects 0.000 description 5
- 102000014150 Interferons Human genes 0.000 description 4
- 108010050904 Interferons Proteins 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229940079322 interferon Drugs 0.000 description 4
- IGWDEVSBEKYORK-UHFFFAOYSA-N isoimperatorin Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)C IGWDEVSBEKYORK-UHFFFAOYSA-N 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 235000005875 quercetin Nutrition 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 235000021028 berry Nutrition 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000006806 disease prevention Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940089161 ginsenoside Drugs 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000002262 irrigation Effects 0.000 description 3
- 238000003973 irrigation Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229940124595 oriental medicine Drugs 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- FCSSPCOFDUKHPV-UHFFFAOYSA-N 2-Propenyl propyl disulfide Chemical compound CCCSSCC=C FCSSPCOFDUKHPV-UHFFFAOYSA-N 0.000 description 2
- ZPSAEGUNYMEKBP-UHFFFAOYSA-N 5-Isopentenyloxy-psoralen Natural products CC(C)C=COc1c2C=CC(=O)Oc2cc3occc13 ZPSAEGUNYMEKBP-UHFFFAOYSA-N 0.000 description 2
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 2
- BEYIWVKWKJROGZ-UHFFFAOYSA-N Alloimperatorin Natural products O1C(=O)C=CC2=C1C(O)=C1OC=CC1=C2OCC=C(C)C BEYIWVKWKJROGZ-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- PKRPFNXROFUNDE-LLVKDONJSA-N Byakangelicin Chemical compound O1C(=O)C=CC2=C1C(OC[C@@H](O)C(C)(C)O)=C1OC=CC1=C2OC PKRPFNXROFUNDE-LLVKDONJSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- KGGUASRIGLRPAX-UHFFFAOYSA-N Meranzin hydrate Natural products C1=CC(=O)OC2=C(CC(O)C(C)(C)O)C(OC)=CC=C21 KGGUASRIGLRPAX-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- PVLHOJXLNBFHDX-XHJPDDKBSA-N Panaxadiol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(CC[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 PVLHOJXLNBFHDX-XHJPDDKBSA-N 0.000 description 2
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 2
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 2
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 2
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 2
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 2
- 235000010081 allicin Nutrition 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000004531 blood pressure lowering effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- PFRGXCVKLLPLIP-UHFFFAOYSA-N diallyl disulfide Chemical compound C=CCSSCC=C PFRGXCVKLLPLIP-UHFFFAOYSA-N 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 2
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 2
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 2
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- -1 isoquerchitrin Chemical compound 0.000 description 2
- XMUPAAIHKAIUSU-QRQCRPRQSA-N kurarinol Chemical compound C1([C@H]2OC=3C(C[C@@H](CCC(C)(C)O)C(C)=C)=C(O)C=C(C=3C(=O)C2)OC)=CC=C(O)C=C1O XMUPAAIHKAIUSU-QRQCRPRQSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000007781 pre-processing Methods 0.000 description 2
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 2
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- QTAGQHZOLRFCBU-CYBMUJFWSA-N (+)-oxypeucedanin Chemical compound CC1(C)O[C@@H]1COC1=C(C=CO2)C2=CC2=C1C=CC(=O)O2 QTAGQHZOLRFCBU-CYBMUJFWSA-N 0.000 description 1
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical group C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 1
- YWHHRFNOJTVNBI-HVVPNVAPSA-N (2r,3r)-2-(2,4-dihydroxyphenyl)-3,7-dihydroxy-8-[(2r)-5-hydroxy-5-methyl-2-prop-1-en-2-ylhexyl]-5-methoxy-2,3-dihydrochromen-4-one Chemical compound C1([C@H]2OC=3C(C[C@@H](CCC(C)(C)O)C(C)=C)=C(O)C=C(C=3C(=O)[C@@H]2O)OC)=CC=C(O)C=C1O YWHHRFNOJTVNBI-HVVPNVAPSA-N 0.000 description 1
- YWHHRFNOJTVNBI-LBEFLKDASA-N (2r,3s)-2-(2,4-dihydroxyphenyl)-3,7-dihydroxy-8-[(2r)-5-hydroxy-5-methyl-2-prop-1-en-2-ylhexyl]-5-methoxy-2,3-dihydrochromen-4-one Chemical compound C1([C@H]2OC=3C(C[C@@H](CCC(C)(C)O)C(C)=C)=C(O)C=C(C=3C(=O)[C@H]2O)OC)=CC=C(O)C=C1O YWHHRFNOJTVNBI-LBEFLKDASA-N 0.000 description 1
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- SHCBCKBYTHZQGZ-PHFGEWBZSA-N (3s,5r,6s,8r,9r,10r,12r,13r,14s,17s)-17-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene-3,6,12-triol Chemical group C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-PHFGEWBZSA-N 0.000 description 1
- PIAPWPAWQGDOMN-SXAWMYDMSA-N (e)-1-[2,4-dihydroxy-6-methoxy-3-[(2r)-5-methyl-2-prop-1-en-2-ylhex-4-enyl]phenyl]-3-(2,4-dihydroxyphenyl)prop-2-en-1-one Chemical compound COC1=CC(O)=C(C[C@@H](CC=C(C)C)C(C)=C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1O PIAPWPAWQGDOMN-SXAWMYDMSA-N 0.000 description 1
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 244000151012 Allium neapolitanum Species 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- ORBITTMJKIGFNH-LLVKDONJSA-N Byakangelicol Chemical compound C1=2OC(=O)C=CC=2C(OC)=C2C=COC2=C1OC[C@H]1OC1(C)C ORBITTMJKIGFNH-LLVKDONJSA-N 0.000 description 1
- ZLDODTPRRLQGHP-LGYCOIBBSA-N C[C@H]1C[C@@H](O)[C@@H](C(C)(C)O)CC2=C(C)C(=O)C[C@H]12 Chemical compound C[C@H]1C[C@@H](O)[C@@H](C(C)(C)O)CC2=C(C)C(=O)C[C@H]12 ZLDODTPRRLQGHP-LGYCOIBBSA-N 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010069767 H1N1 influenza Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N Icarin Chemical compound C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- PIAPWPAWQGDOMN-UHFFFAOYSA-N Kuraridine Natural products COC1=CC(O)=C(CC(CC=C(C)C)C(C)=C)C(O)=C1C(=O)C=CC1=CC=C(O)C=C1O PIAPWPAWQGDOMN-UHFFFAOYSA-N 0.000 description 1
- YWHHRFNOJTVNBI-RJZKYMFLSA-N Kushenol H Natural products O(C)c1c2C(=O)[C@H](O)[C@H](c3c(O)cc(O)cc3)Oc2c(C[C@@H](C(=C)C)CCC(O)(C)C)c(O)c1 YWHHRFNOJTVNBI-RJZKYMFLSA-N 0.000 description 1
- YWHHRFNOJTVNBI-KBOJRLNKSA-N Kushenol K Natural products O(C)c1c2C(=O)[C@H](O)[C@@H](c3c(O)cc(O)cc3)Oc2c(C[C@@H](C(=C)C)CCC(O)(C)C)c(O)c1 YWHHRFNOJTVNBI-KBOJRLNKSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- QTAGQHZOLRFCBU-UHFFFAOYSA-N Oxypeucadanin Natural products CC1(C)OC1COC1=C(C=CO2)C2=CC2=C1C=CC(=O)O2 QTAGQHZOLRFCBU-UHFFFAOYSA-N 0.000 description 1
- NUCBCBCPICFGMZ-UHFFFAOYSA-N Oxypeucedanin Natural products CC1(C)OC1COC1=CC(=O)OC2=C1C=C1C=COC1=C2 NUCBCBCPICFGMZ-UHFFFAOYSA-N 0.000 description 1
- MWEVYJRFLDKUCW-UHFFFAOYSA-N Oxypeucedonin-hydrat Natural products CC(C)(O)C(O)Cc1c2C=CC(=O)Oc2cc3occc13 MWEVYJRFLDKUCW-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- IQWVFAXBJQKUDH-TXCQZRSTSA-N [(5s,6r,8s,8ar)-5-(2-acetyloxypropan-2-yl)-3,8-dimethyl-2-oxo-4,5,6,7,8,8a-hexahydro-1h-azulen-6-yl] (z)-2-methylbut-2-enoate Chemical compound C1[C@H](C(C)(C)OC(C)=O)[C@H](OC(=O)C(\C)=C/C)C[C@H](C)[C@H]2CC(=O)C(C)=C21 IQWVFAXBJQKUDH-TXCQZRSTSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000000842 anti-protozoal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000008321 arterial blood flow Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- PKRPFNXROFUNDE-UHFFFAOYSA-N biac-angelicin Natural products O1C(=O)C=CC2=C1C(OCC(O)C(C)(C)O)=C1OC=CC1=C2OC PKRPFNXROFUNDE-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 239000002371 cardiac agent Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- FRBORWNVTCITAQ-UHFFFAOYSA-N ferulin Natural products C1=C2C(C)=CC(=O)C2=C(C)CC2OC(=O)C(C)C21 FRBORWNVTCITAQ-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930002879 flavonoid pigment Natural products 0.000 description 1
- 150000004638 flavonoid pigments Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 1
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 125000001741 organic sulfur group Chemical group 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- HRWVKZXRZVVBLP-UHFFFAOYSA-N oxypeucedanin hydrate Natural products CC(C)(O)C(O)CCc1c2C=CC(=O)Oc2cc3occc13 HRWVKZXRZVVBLP-UHFFFAOYSA-N 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229930008679 prenylflavonoid Natural products 0.000 description 1
- 150000007951 prenylflavonoids Chemical class 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 229910052604 silicate mineral Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- IQWVFAXBJQKUDH-HJYBKFAWSA-N torilin Natural products O=C(O[C@H]1[C@@H](C(OC(=O)C)(C)C)CC2=C(C)C(=O)C[C@@H]2[C@@H](C)C1)/C(=C/C)/C IQWVFAXBJQKUDH-HJYBKFAWSA-N 0.000 description 1
- ZLDODTPRRLQGHP-UHFFFAOYSA-N torilolone Natural products CC1CC(O)C(C(C)(C)O)CC2=C(C)C(=O)CC12 ZLDODTPRRLQGHP-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G22/00—Cultivation of specific crops or plants not otherwise provided for
- A01G22/35—Bulbs; Alliums, e.g. onions or leeks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C05—FERTILISERS; MANUFACTURE THEREOF
- C05D—INORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C; FERTILISERS PRODUCING CARBON DIOXIDE
- C05D1/00—Fertilisers containing potassium
-
- C—CHEMISTRY; METALLURGY
- C05—FERTILISERS; MANUFACTURE THEREOF
- C05D—INORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C; FERTILISERS PRODUCING CARBON DIOXIDE
- C05D9/00—Other inorganic fertilisers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Environmental Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 법제액상유황 및 세리사이트를 시비하여 재배한 산양삼, 마늘, 대추 및 적양파를 주원료로 함으로써 우수한 항바이러스 기능을 제공할 수 있는 면역력 증강용 기능성 음료의 제조방법을 개시한다. The present invention discloses a method of manufacturing a functional beverage for enhancing immunity that can provide excellent antiviral function by using wild ginseng, garlic, jujube and red onion grown by fertilizing legal liquid sulfur and sericite as main raw materials.
Description
본 발명은 법제액상유황과 세리사이트를 시비하여 재배된 산양삼, 마늘 및 대추와, 법제액상유황과 세리사이트를 시비하여 재배된 적양파로부터 추출된 적양파추출물을 주성분으로 함유하는 면역력 증강을 위한 기능성 음료의 제조방법에 관한 것이다. The present invention is functional for enhancing immunity containing, as main components, wild ginseng, garlic and jujube grown by fertilizing legal liquid sulfur and sericite, and red onion extract extracted from red onion grown by fertilizing legal liquid sulfur and sericite. It relates to a method for manufacturing a beverage.
면역은 태어날 때부터 지니고 있는 선천 면역(innate immunity)과 후천적으로 생활하면서 적응되어 얻어지는 획득 면역(acquired immunity)으로 구분될 수 있다. 선천 면역은 일명 '자연 면역'이라고도 하며, 항원에 대해 비특이적으로 반응하고, 특별한 기억작용은 없는 것을 특징으로 한다.Immunity can be divided into innate immunity, which is possessed from birth, and acquired immunity, which is acquired by living adaptively. Innate immunity, also called 'natural immunity', is characterized by non-specific responses to antigens and no special memory action.
최근 들어, 생체 내 선천적 방어 면역시스템 중에서 인터페론(interferon)에 의해 유도되는 선천성 면역분야가 주목을 받고 있는데, 인터페론 매개 면역의 활성화는 다양한 전염병 병원체에 대한 근본적인 예방 방법이 될 수 있기 때문이다. 이에, 인터페론 활성화 기전 연구 및 인터페론을 유도시킬 수 있는 면역조절제제의 개발 연구가 활발하게 진행되고 있다.Recently, the field of innate immunity induced by interferon among the innate defense immune system in vivo has been attracting attention, because the activation of interferon-mediated immunity can be a fundamental prevention method against various infectious disease pathogens. Accordingly, studies on the mechanism of interferon activation and development of immunomodulatory agents capable of inducing interferon are being actively conducted.
한편, 병원체의 감염에 따른 선천 면역의 방어 기작의 하나로 사이토카인 같은 면역 인자가 분비되는데, 이들에 의해 면역 반응이 일어나고 병원체에 대한 방어가 이루어진다. 따라서 선천 면역 반응을 유도함으로써 다양한 전염병 병원체 대한 예방 및 치료 방법이 될 수 있으며, 이를 유도시킬 수 있는 선천면역의 증진 제제에 대한 연구가 필요하다.On the other hand, immune factors such as cytokines are secreted as one of the defense mechanisms of innate immunity according to the infection of the pathogen, whereby an immune response occurs and defense against the pathogen is made. Therefore, it can be a preventive and therapeutic method for various infectious disease pathogens by inducing an innate immune response, and research on agents for enhancing innate immunity that can induce it is needed.
바이러스(virus)는 라틴어로 독성물질을 의미하며, 세균여과지(022㎛)를 통과하는 일군의 감염형 병원성 입자이다. 바이러스는 숙주세포의 종류에 따라 박테리오파지, 식물 바이러스, 동물 바이러스로 분류하기도 하며, 핵산의 종류에 따라 DNA 바이러스, RNA 바이러스로 분류할 수 있다. 최근 신종 플루, AI 및 구제역 등 다양한 바이러스 질병이 사회적으로 큰 문제를 일으켰으며, 이에 따라 바이러스 질병의 효과적인 대책에 대한 고민이 사회적으로 큰 관심을 불러일으키고 있다.Virus means a toxic substance in Latin, and is a group of infectious pathogenic particles that pass through a bacterial filter paper (022㎛). Viruses can be classified into bacteriophages, plant viruses, and animal viruses according to the type of host cell, and can be classified into DNA viruses and RNA viruses according to the types of nucleic acids. Recently, various viral diseases such as H1N1 influenza, AI and foot-and-mouth disease have caused great social problems, and accordingly, concerns about effective countermeasures for viral diseases are arousing great social interest.
현재 바이러스성 질병을 예방하기 위한 가장 좋은 방법은 백신접종이지만, 바이러스에 의한 질병의 경우, 대체로 많은 바이러스 혈청형(아형) 생성 등에 따른 백신의 효율성 문제가 중요하게 제기되고 있다. Currently, the best method for preventing viral diseases is vaccination, but in the case of diseases caused by viruses, the effectiveness of vaccines due to the generation of many viral serotypes (subtypes) is being raised as an important issue.
이러한 백신의 효율성 문제제기로 인하여 최근 해외 및 국내에서 기존의 항바이러스제의 단점을 극복하고자 하는 많은 노력들이 이루어지고 있으며, 그 중의 하나로 국내에서는 생약 추출물 및 식물 추출물을 대상으로 항바이러스 효능에 대한 연구가 진행중이기는 하지만, 아직까지는 미비한 실정이다. Due to the issue of the effectiveness of these vaccines, many efforts are being made to overcome the shortcomings of existing antiviral drugs abroad and in Korea. Although it is in progress, it is still incomplete.
이에, 기존의 항바이러스 제제의 단점을 극복하여 독성 및 부작용이 거의 없이 우수한 선천면역 증진 효과 및 항바이러스 활성을 발휘할 수 있는 생약 추출물을 유효성분으로 하는 조성물의 개발이 필요한 실정이다.Accordingly, there is a need to develop a composition comprising, as an active ingredient, a herbal extract capable of overcoming the disadvantages of the existing antiviral agent and exhibiting excellent innate immunity enhancing effect and antiviral activity with almost no toxicity and side effects.
본 발명은 상기와 같은 문제점을 해결하기 위하여 발명된 것으로, 법제액상유황과 세리사이트를 시비하여 재배된 산양삼, 마늘 및 대추와, 법제액상유황과 세리사이트를 시비하여 재배된 적양파로부터 추출된 적양파추출물을 주성분으로 함유하는 면역력 증강을 위한 기능성 음료의 제조방법을 제공하는데 그 목적이 있다. The present invention was invented to solve the above problems, and is extracted from wild ginseng, garlic and jujube grown by fertilizing legal liquid sulfur and sericite, and red onion grown by fertilizing legal liquid sulfur and sericite. An object of the present invention is to provide a method of manufacturing a functional beverage for enhancing immunity containing onion extract as a main ingredient.
상기와 같은 목적을 위하여 산양삼, 대추, 육두구, 감초, 삼백초, 창출, 백출, 지구자, 익모초, 황기, 계피로 구성되는 원료를 전처리하여 준비하는 단계와; 상기 원료를 물에 투입한 다음 80~120℃로 5~7시간 가열하여 원료액을 조성하는 단계와; 상기 원료액에 전처리된 마늘을 첨가한 다음 60~70℃ 10~15시간 가열한 후 압착하여 추출액을 조성하는 단계와; 상기 추출액을 여과한 후 적양파추출물과 벌꿀, 죽염을 첨가한 후 교반탱크에서 80~120℃로 5~7시간 가열 및 교반하는 단계;를 포함하는 것을 특징으로 한다. Preparing by pre-processing raw materials consisting of wild ginseng, jujube, nutmeg, licorice, ginseng, chrysanthemum, baekchul, guja, motherwort, astragalus, and cinnamon for the above purpose; preparing a raw material solution by adding the raw material to water and then heating it at 80 to 120° C. for 5 to 7 hours; preparing an extract by adding pre-treated garlic to the raw material solution and then heating at 60 to 70° C. for 10 to 15 hours and pressing; After filtering the extract, red onion extract, honey, and bamboo salt are added, and then heated and stirred at 80 to 120° C. for 5 to 7 hours in a stirring tank; characterized in that it comprises a.
또한, 본 발명에서 상기 원료액을 조성하는 단계는 물 1.2ton에 대하여 산양삼 10kg, 대추 20kg, 육두구 10kg, 감초 10kg, 삼백초 10kg, 창출 5kg, 백출 5kg, 지구자 10kg, 익모초 5kg, 황기 20kg 및 계피 10kg가 투입되고, 상기 추출액을 조성하는 단계는 원료액 1ton에 대하여 마늘 10kg이 첨가되며, 상기 가열 및 교반단계는 추출액 1ton에 대하여 적양파추출물 3kg, 벌꿀 2kg, 죽염 50g이 첨가되는 것을 특징으로 한다. In addition, in the present invention, the step of composing the raw material solution is for 1.2 tons of water,
또한, 본 발명은 인삼, 대추, 감초, 삼백초, 음양곽, 곽향, 지구자, 사상자, 백지, 고삼, 계피로 구성되는 원료를 전처리하여 준비하는 단계와; 상기 원료를 물에 투입한 다음 80~120℃로 5~7시간 가열하여 원료액을 조성하는 단계와; 상기 원료액에 전처리된 마늘을 첨가한 다음 60~70℃ 10~15시간 가열한 후 압착하여 추출액을 조성하는 단계와; 상기 추출액을 여과한 후 적양파추출물과 벌꿀, 강황소금을 첨가한 후 교반탱크에서 80~120℃로 5~7시간 가열 및 교반하는 단계;를 포함하는 것을 특징으로 한다. In addition, the present invention includes the steps of pre-treating and preparing raw materials consisting of ginseng, jujube, licorice, ginseng, yinyanggwak, gwakhyang, jijija, casualty, white paper, old ginseng, and cinnamon; preparing a raw material solution by adding the raw material to water and then heating it at 80 to 120° C. for 5 to 7 hours; preparing an extract by adding pre-treated garlic to the raw material solution and then heating at 60 to 70° C. for 10 to 15 hours and pressing; After filtering the extract, red onion extract, honey, and turmeric salt are added, and then heated and stirred in a stirring tank at 80 to 120° C. for 5 to 7 hours.
또한, 본 발명에서 상기 원료액을 조성하는 단계는 물 1.2ton에 대하여 인삼10kg, 대추 20kg, 감초15kg, 삼백초 15kg, 음양곽 5kg, 곽향 5kg, 지구자 5kg, 사상자 5kg, 백지5kg, 고삼 5kg 및 계피 15kg가 투입되고, 상기 추출액을 조성하는 단계는 원료액 1ton에 대하여 마늘 20kg이 첨가되며, 상기 가열 및 교반단계는 추출액 1ton에 대하여 적양파추출물 3kg, 벌꿀 2kg, 강황소금 50g이 첨가되는 것을 특징으로 한다. In addition, the step of composing the raw material solution in the present invention for 1.2 tons of water ginseng 10kg, jujube 20kg, licorice 15kg, ginseng 15kg, eumyanggwak 5kg, gwakhyang 5kg, earth ruler 5kg, dead 5kg, white paper 5kg, old ginseng 5kg and cinnamon 15 kg is added, and in the step of composing the extract, 20 kg of garlic is added per 1 ton of the raw material solution, and in the heating and stirring step, 3 kg of red onion extract, 2 kg of honey, and 50 g of turmeric salt are added per 1 ton of the extract. do.
또한, 본 발명에서 상기 산양삼, 인삼, 마늘, 대추는 법제액상유황 및 세리사이트를 시비하여 재배된 것이며, 상기 적양파추출물은 법제액상유황 및 세리사이트를 시비하여 재배된 적양파로부터 추출된 것을 특징으로 하는 면역력 증강을 위한 기능성 음료의 제조방법.In addition, in the present invention, the wild ginseng, ginseng, garlic, and jujube are grown by fertilizing legal liquid sulfur and sericite, and the red onion extract is extracted from red onions grown by fertilizing legal liquid sulfur and sericite. A method of manufacturing a functional beverage for enhancing immunity.
상기와 같이 이루어지는 본 발명은 산양삼, 마늘, 대추 및 적양파에 법제액상유황 및 세리사이트를 시비하여 재배함으로써 작물에 충분한 유황성분을 공급할 수 있고, 이를 통해 열매 또는 결실부에 질소, 인산, 유황 및 인과 칼륨 성분의 영양분이 많이 집적되어 양질의 작물을 재배할 수 있다. 특히, 산양삼의 경우 법제액상유황 및 세리사이트를 시비하지 않은 대조구에 비해 진세노사이드의 함량이 10~27배 증폭되며, 마늘과 적양파의 경우 시스틴, 알리신 성분이 대조구 대비 4배 이상 증폭되는 효과가 있다. 따라서, 이러한 과정을 거쳐 재배되는 원료로부터 조성되는 본 발명에 따른 면역력 증강용 기능성 음료는 우수한 항바이러스 기능을 제공할 수 있다. The present invention made as described above can supply sufficient sulfur components to crops by fertilizing and cultivating wild ginseng, garlic, jujube and red onion with legal liquid sulfur and sericite, and through this, nitrogen, phosphoric acid, sulfur and Nutrients of phosphorus and potassium components are accumulated a lot, so good quality crops can be cultivated. In particular, in the case of wild ginseng, the content of ginsenoside is amplified 10 to 27 times compared to the control that is not fertilized with legal liquid sulfur and sericite, and in the case of garlic and red onion, the cystine and allicin components are amplified 4 times or more compared to the control. there is Therefore, the functional beverage for enhancing immunity according to the present invention, which is prepared from raw materials grown through this process, can provide excellent antiviral function.
도 1은 본 발명의 바람직한 실시예에 따른 면역력 증강용 기능성 음료의 제조공정도.
도 2a) 및 2b)는 본 발명의 일실시예에 따른 산양삼의 시험성적서.1 is a manufacturing process diagram of a functional beverage for enhancing immunity according to a preferred embodiment of the present invention.
2a) and 2b) are test reports of wild ginseng according to an embodiment of the present invention.
이하, 본 발명의 바람직한 실시예를 첨부된 도면들을 참조하여 상세히 설명한다. 우선 각 도면의 구성요소들에 참조부호를 부가함에 있어서, 동일한 구성요소들에 대해서는 비록 다른 도면상에 표시되더라도 가능한 한 동일한 부호를 가지도록 하고 있음에 유의해야 한다. 또한, 본 발명을 설명함에 있어, 관련된 공지 구성 또는 기능에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명은 생략한다.Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings. First of all, in adding reference numerals to the components of each drawing, it should be noted that the same components are given the same reference numerals as much as possible even though they are indicated on different drawings. In addition, in describing the present invention, if it is determined that a detailed description of a related known configuration or function may obscure the gist of the present invention, the detailed description thereof will be omitted.
본 발명은 법제액상유황과 세리사이트를 시비하여 재배된 산양삼, 마늘 및 대추와, 법제액상유황과 세리사이트를 시비하여 재배된 적양파로부터 추출된 적양파추출물을 주성분으로 함유하는 면역력 증강을 위한 기능성 음료의 제조방법을 개시한다. The present invention is functional for enhancing immunity containing, as main components, wild ginseng, garlic and jujube grown by fertilizing legal liquid sulfur and sericite, and red onion extract extracted from red onion grown by fertilizing legal liquid sulfur and sericite. Disclosed is a method for preparing a beverage.
도 1은 본 발명의 바람직한 실시예에 따른 면역력 증강용 기능성 음료의 제조방법을 나타내는 제조공정도로서, 본 발명은 원료준비단계(S1)와, 원료액 조성단계(S2)와, 추출액 조성단계(S3)와, 가열 및 교반단계(S4)를 포함한다. 1 is a manufacturing process diagram showing a manufacturing method of a functional beverage for enhancing immunity according to a preferred embodiment of the present invention, wherein the present invention includes a raw material preparation step (S1), a raw material composition step (S2), and an extract liquid composition step (S3) and a heating and stirring step (S4).
먼저, 상기 원료준비단계(S1)는 본 발명의 실시예에 따라 조성되는 면역력 증강용 기능성 음료의 원료를 준비하는 단계로서, 산양삼, 대추, 육두구, 감초, 삼백초, 창출, 백출, 지구자, 익모초, 황기, 계피를 각각 선별 및 세척하여 준비하는 단계이다. First, the raw material preparation step (S1) is a step of preparing the raw material of a functional beverage for enhancing immunity prepared according to an embodiment of the present invention, wild ginseng, jujube, nutmeg, licorice, sambaekcho, creation, baekchul, earthworm, motherwort , Astragalus, and cinnamon are selected and washed, respectively, and prepared.
일반적으로 인삼은 밭이나 그늘막에서 비료, 농약을 통해 재배된 삼을 의미고, 산삼은 산에서 자연적으로 생장한 삼을 의미한다. In general, ginseng refers to ginseng grown through fertilizers and pesticides in fields or shade screens, and wild ginseng refers to ginseng grown naturally in the mountains.
본 발명은 산지에서 차광막 등 인공시설을 설치하지 아니하고 무농약으로 재배되는 삼을 사용하며, '전초'를 사용한다. 여기에서, '전초'라 함은 삼의 뿌리, 줄기 및 잎을 포함한 전체를 의미한다. 본 발명에서 상기 산양삼 전초는 7년근 이상을 사용하며, 바람직하게는 7년근의 산양삼 전초를 사용한다. The present invention uses ginseng grown without pesticides without installing artificial facilities such as shading screens in production areas, and uses 'outpost'. Here, the term 'outpost' means the whole including the root, stem, and leaf of ginseng. In the present invention, the wild ginseng outpost is 7 years old or more, and preferably 7 year old wild ginseng outpost is used.
한편, 인삼의 여러 가지 유효성분 중 주된 약리작용을 하는 것이 사포닌(saponin)이다. 사포닌(saponin)은 식물계에 널리 분포하는 트리텔펜 및 스테로이드계의 배당체의 총칭으로, 예전에는 비영양물질로 알려졌으나, 항암, 항산화, 콜레스테롤 저하 효과가 밝혀지면서 생리활성물질로 각광받기 시작했다. 한방약에서는 강심제나 이뇨제로 사용되어 왔으며, 특히 인삼 사포닌은 다른 식물에서 발견되는 사포닌과는 다른 특이한 화학 구조를 가지고 있으며, 약리 효능도 특이하여 인산(Ginseng) 배당체(Glycoside)란 의미로 '진세노사이드(Ginsenoside)'라고도 부른다. On the other hand, saponin is the main pharmacological action among various active ingredients of ginseng. Saponin is a generic term for triterpene and steroidal glycosides widely distributed in the plant world. In oriental medicine, ginseng saponin has been used as a cardiac agent or a diuretic. In particular, ginseng saponin has a unique chemical structure different from saponin found in other plants, and has a unique pharmacological effect. Also called 'Ginsenoside'.
특히, 산양삼의 사포닌 함량은 protopanaxadiol group(RD)과 protopanaxtriol group(RT)의 비율에 있어서 325%로, 재배삼 4 년생 245%와 6 년근 218%에 비하여 높은 것으로 알려져 있으며, 특히 ginsenoside Rb1 과 ginsenoside Rg1의 비율에 있어서 재배삼은 4 년근에서 351%, 6 년근에서 486%에 비하여 산양삼이 1022%로 높은 것으로 알려져 있다. 이외에 ginsenoside Rb1, Rd, Re는 함량도 재배삼에 비하여 산양삼이 높게 나타나는 것으로 알려져 있다. 뿐만 아니라 TAC, ORAC, phenol 함량과 ROS 생성억제 등의 효과에서도 산양삼이 인삼보다 높은 것으로 알려져 있다. 또한, 사포닌 이외의 산양삼에 포함된 다수의 성분들 또한 항염증 작용, 면역기능 증강 등에 효능이 있는 것으로 알려져 있다.In particular, the saponin content of wild ginseng is 325% in the proportion of protopanaxadiol group (RD) and protopanaxtriol group (RT), which is known to be higher than that of 4 year old cultivated ginseng 245% and 6 year old 218%. As for the ratio, it is known that wild ginseng is 1022% higher than that of cultivated ginseng at 351% and 6 years old at 486%. In addition, the content of ginsenoside Rb1, Rd, and Re is also known to be higher in wild ginseng than in cultivated ginseng. In addition, wild ginseng is known to be higher than ginseng in the effects of TAC, ORAC, phenol content and ROS production inhibition. In addition, a number of components contained in wild ginseng other than saponin are also known to be effective in anti-inflammatory action, immune function enhancement, and the like.
대추는 신경 쇠약이나 빈혈증, 식용부진, 약물의 독성을 풀어주는 효능이 인정되었으며, 부인냉병에 효과적이다. 위의 기능을 편하게 하고 위장을 튼튼하게 하여 몸이 차고 소화기관이 약한 사람에게 좋은 약재이다. 대추의 단맛은 정신적 안정을 주어 불면증에 효과가 있고, 노화방지 및 항암 효과가 있어 대추의 식이성 섬유가 발암물질을 흡착해 몸 밖으로 밀어내며, 베타카로틴으로 체내 유해 활성산소를 제거하는 효과도 있다. 또한, 간 기능의 활성화, 감기 예방 및 이뇨작용을 촉진하고, 강장 해독 효과 및 근육의 긴장완화, 관절염에 효과가 있다.Jujubes have been recognized for their efficacy in relieving neurasthenia, anemia, poor eating, and drug toxicity, and are effective in treating gynecological cold. It is a good medicine for those who have a cold and weak digestive system by facilitating the function of the stomach and strengthening the stomach. The sweet taste of jujube gives mental stability, which is effective for insomnia, and has anti-aging and anti-cancer effects, so the dietary fiber of jujube absorbs carcinogens and pushes them out of the body, and beta-carotene also has the effect of removing harmful free radicals in the body. . In addition, it promotes the activation of liver function, prevention of colds and diuresis, and has a tonic detoxification effect, relieves muscle tension, and is effective in arthritis.
육두구는 인도네시아 몰루카제도 원산으로서, 잎은 어긋나고 긴 타원형이며 가장자리가 밋밋하고 두껍다. 성숙하면 붉은빛을 띤 노란색 껍질이 벌어져서 안쪽에 갈빗대처럼 갈라진 종의(種衣)가 보이는데, 종자를 육두구, 종의를 메이스(mace)라고 한다. 영어 이름인 너트메그란 사향 향기가 나는 호두라는 뜻이다. 번식은 대부분 종자로 하고 고온, 다습한 기후에서 잘 자란다. 육두구는 말려서 방향성 건위제·강장제 등으로 쓴다. Nutmeg is native to the Molucca Islands of Indonesia. The leaves are alternate, long oval, and the edges are flat and thick. When mature, the reddish-yellow shell opens to reveal a species that is split like a rib inside. The seeds are called nutmeg, and the species is called mace. The English name, Nutmeg, means walnut with a musky scent. Propagation is mostly done by seeds and grows well in high temperature and humid climates. Nutmeg is dried and used as a flavoring agent and tonic.
감초는 약효를 강화시키며, 기침 개선, 소염작용 및 해독작용, 피부질환개선, 위 보호, 노화방지, 성인병 예방, 항암효능, 숙취해소, 간질환 예방, 생리작용의 활성화, 근력 강화, 동맥경화예방, 편도선, 늑막염, 폐결핵 등을 완화 시키며, 여성갱년기 증상 등에 효과가 있다.Licorice enhances medicinal effects, and improves cough, anti-inflammatory and detoxification, skin disease improvement, stomach protection, anti-aging, adult disease prevention, anti-cancer effect, hangover relief, liver disease prevention, physiological action activation, muscle strength strengthening, arteriosclerosis prevention , tonsils, pleurisy, pulmonary tuberculosis, etc., and is effective for female menopausal symptoms.
삼백초는 쿠에르치트린, 이소쿠에르치트린, 쿠에르체틴, 루틴 등 프라본계 물질에 의한 말초혈관 보호 및 강화작용에 의해 출혈하기 쉬운 모세혈관의 탄력성이 정상적으로 회복되므로 중풍예방에 크게 도움이 되며 심장의 수축력 또한 증가시켜준다. 특히 관상혈관을 확장시켜 각종 심장질환을 개선시킨다. 또한, 프라본게 물질의 완화작용으로 변비가 해소되며, 원활한 이뇨작용에 의해 각종전립선 질병 및 요독증 등을 예방해준다. 또한 간장의 해독력을 도와 알콜 및 각종 유해독소를 빠른 시간에 분해시킨다. 수용성탄닌은 탄고기의 발암성을 억제하고 장속의 유산균을 증식시키며 혈소판의 응고를 막아 혈전이 생기지 않게 하며, 유행성 감기의 바이러스 감염을 막아주는데 효과가 있다.As the elasticity of capillaries, which are prone to bleeding, is restored to normal by the protective and strengthening action of peripheral blood vessels by flavone substances such as quercitrin, isoquerchitrin, quercetin, and rutin, it is very helpful in preventing stroke. It also increases the contractile force of the heart. In particular, it improves various heart diseases by dilating coronary blood vessels. In addition, it relieves constipation by the alleviating action of flavonge substances, and prevents various prostate diseases and uremia by smooth diuretic action. In addition, it helps the liver to detoxify and quickly decomposes alcohol and various harmful toxins. Water-soluble tannins are effective in inhibiting carcinogenicity of tannins, proliferating lactic acid bacteria in the intestines, preventing platelets from clotting, preventing blood clots, and preventing viral infections of influenza.
창출은 국화과 여러해 살이의 풀로, 한방에서는 뿌리 줄기를 발한(發汗, 피부의 땀샘에서 땀을 분비시킴), 진통, 이뇨, 건위 등에 효능이 있으며, 식욕부진, 소화불량, 감기, 위장염 등에 우수한 효과를 제공한다. Chrysanthemum is a perennial herb of the Asteraceae family, and in oriental medicine, it is effective in sweating (發汗, sweat glands in the skin), analgesic, diuresis, and stomach. to provide.
백출은 삽주의 뿌리를 건조시킨 약재로, 주요 성분인 향기름이 중추 신경에 대하여 적은 양에서는 진정(鎭靜) 작용을, 많은 양에서는 마비 작용을 나타내며 소화를 돕는다.Baekchul is a medicinal herb obtained by drying the roots of sapju, and its main ingredient, fragrant oil, acts as a sedative for the central nervous system in small amounts, and paralyzes in large amounts to aid digestion.
지구자(Hoveniae Semen Cum Fructus)는 갈매나무과의 헛개나무의 과병을 가진 열매 또는 씨를 말하는 것으로, 열병으로 인한 번열, 구갈, 딸국질, 구토 등에 쓰이며, 이뇨를 돕고, 알코올 중독으로 손상된 간장을 치료하는 효과가 있으며, 혈액순환을 돕고 근육을 풀어주는 효과가 있다. Hoveniae Semen Cum Fructus refers to the fruit or seeds with the fruit of the buckthorn family. It is used for fever, dry mouth, nausea, vomiting, etc. due to fever, helps diuresis, and has the effect of treating the liver damaged by alcohol poisoning. It has the effect of improving blood circulation and relaxing muscles.
익모초는 혈압강하·이뇨·진정·진통 작용을 한다. 포기 전체를 말려서 산후의 지혈과 복통에 사용하기도 한다. Motherwort has a blood pressure lowering, diuretic, calming, and analgesic effect. It is also used for postpartum hemostasis and abdominal pain by drying the whole vine.
황기는 콩과 식물인 단너삼의 뿌리를 말린 것으로 강장작용, 면역조절 활성, 항-고혈당 활성(당뇨에 작용), 항염증 활성, 항산화 활성, 항바이러스 활성, 항암작용에 효능이 있다.Astragalus is the dried root of ginseng, a legume, which has tonic, immunomodulatory, anti-hyperglycemic activity (action on diabetes), anti-inflammatory activity, antioxidant activity, antiviral activity, and anticancer activity.
계피는 혈액순환을 촉진시켜 흉복부의 냉증을 제거하며 식욕을 증진시키고 소화 촉진을 돕는다. 또한, 위장의 경련성 통증을 억제하고 위장관의 운동을 촉진해 가스를 배출하고 흡수를 좋게 하며, 장내의 이상발효를 억제하는 방부효과도 있다. 약리작용으로 개선균 억제작용, 백색염주균병 억제작용, 건위작용, 타액 및 위액 분비촉진작용 등이 있다. Cinnamon promotes blood circulation, removes coldness in the chest and abdomen, improves appetite, and helps digestion. In addition, it suppresses stomach cramping pain, promotes movement of the gastrointestinal tract, discharges gas, improves absorption, and has an antiseptic effect to inhibit abnormal fermentation in the intestine. As pharmacological action, there are improving bacteria suppression action, white salt bacillus suppression action, gastric action, and salivary and gastric juice secretion promoting action.
다음으로, 상기 원료액 조성단계(S2)는 상기 전치리된 원료를 물에 투입한 다음 가열하여 원료액을 조성하는 단계이다. Next, the raw material solution composition step (S2) is a step of preparing the raw material solution by adding the pretreated raw material to water and then heating it.
바람직하게는 상기 원료액을 조성하는 단계는 물 1.2ton에 대하여 산양삼 10kg, 대추 20kg, 육두구 10kg, 감초 10kg, 삼백초 10kg, 창출 5kg, 백출 5kg, 지구자 10kg, 익모초 5kg, 황기 20kg 및 계피 10kg가 투입되며, 80~120℃로 5~7시간 가열하여 원료액을 조성한다. 각 원료가 함량비 미만으로 첨가되면 함량미달로 인해 원료로부터 제공되는 효과를 기대하기 어려우므로 바람직하지 않다. Preferably, the step of composing the raw material solution contains 10 kg of wild ginseng, 20 kg of jujube, 10 kg of nutmeg, 10 kg of licorice, 10 kg of ginseng, 5 kg of ginseng, 5 kg of baekchul, 10 kg of earthworm, 5 kg of motherwort, 20 kg of astragalus and 10 kg of cinnamon with respect to 1.2 tons of water. It is added and heated at 80~120℃ for 5~7 hours to form a raw material solution. When each raw material is added in less than the content ratio, it is not preferable because it is difficult to expect the effect provided from the raw material due to the insufficient content.
다음으로, 상기 추출액 조성단계(S3)는 상기 원료액에 전처리된 마늘을 첨가한 다음 가열한 후 압착하여 추출액을 조성하는 단계이다. Next, the extract solution composition step (S3) is a step of adding pre-treated garlic to the raw material solution, heating it, and then compressing it to form an extract solution.
원료액에 첨가되는 마늘은 강정, 강장, 체력증강, 인체기능과 세포의 화력 증진, 동맥경화, 고혈압, 콜레스테톨 제거, 항암 작용 등 다양한 작용을 한다.Garlic added to the raw material has various actions such as strengthening, tonicity, physical strength enhancement, human body function and cell thermal power enhancement, arteriosclerosis, high blood pressure, cholesterol removal, and anticancer action.
바람직하게는, 상기 원료액 1ton에 대하여 마늘 10kg이 첨가되며, 마늘 첨가 후 60~70℃로 10~15시간 가열한 후 압착하여 추출액을 조성한다. Preferably, 10 kg of garlic is added to 1 ton of the raw material solution, and after adding garlic, it is heated at 60 to 70° C. for 10 to 15 hours and then compressed to form an extract.
다음으로, 상기 가열 및 교반단계(S4)는 상기 추출액에 함유된 이물질, 고형물 등을 여과한 다음 적양파추출물과 벌꿀, 죽염을 첨가한 후 교반탱크에서 가열 및 교반하는 단계이다. Next, the heating and stirring step (S4) is a step of filtering foreign substances, solids, etc. contained in the extract, then adding red onion extract, honey, and bamboo salt, and then heating and stirring in a stirring tank.
적양파는 항산화 작용을 하는 퀘르세틴(quercetin), 퀘르시트린(quercitrin), 루틴(rutin) 등과 같은 플라보노이드(flavonoid)계 색소와 체내 축적된 지방분해 작용을 하는 아릴프로필디설파이드(allyl propyl disulfide) 및 디아릴디설파이드(diallyl disulfide) 등이 함유되어 있는 것으로 알려져 있다. Red onion contains flavonoid pigments such as quercetin, quercitrin, and rutin, which have an antioxidant action, and allyl propyl disulfide and diaryl, which have the action of decomposing accumulated fat in the body. It is known that it contains diallyl disulfide and the like.
또한, 적양파는 중금속 해독작용, 항균효과, 혈당 저하효과, 심·혈관계질환예방효과, 잔틴 산화효소 저해작용, 항산화작용, 항암효과를 제공하며, 비타민 B1, C, 칼슘, 인, 무기질 등이 혈액순환을 촉진시켜 위장 기능을 강화하며 콜레스테롤 제거 및 고혈압, 고지혈증을 예방하는 효과가 있다. In addition, red onion provides heavy metal detoxification, antibacterial effect, blood sugar lowering effect, cardiovascular and vascular disease prevention effect, xanthine oxidase inhibitory action, antioxidant action, and anticancer effect, and contains vitamins B1, C, calcium, phosphorus, minerals, etc. It promotes blood circulation, strengthens gastrointestinal function, removes cholesterol, and prevents high blood pressure and hyperlipidemia.
뿐만 아니라, 적양파는 흰양파에 비해 항산화 물질인 안토시안과 퀘르세틴 함량이 훨씬 높은 편이며 항산화능이 높을수록 발모촉진 효과도 크게 나타난다. 적양파의 성분 중 아래 화합물 1로 표기되는 퀘르세틴(quercetin) 이라는 성분은 최근 많은 연구를 통해 혈관 벽을 튼튼하게 해 동맥경화, 고혈압 등에 효과가 있는 것으로 알려져 있으며 우리 몸의 체내에서 강력한 항산화 작용 및 전신적인 염증 반응을 유발하는 싸이토카인의 분비를 억제하는 항염증 효과도 있는 것으로 보고되고 있다.In addition, the content of anthocyanin and quercetin, which are antioxidants, is much higher in red onion than in white onion, and the higher the antioxidant capacity, the greater the effect of promoting hair growth. Among the ingredients of red onion, quercetin, represented by
(화합물1)(Compound 1)
한편, 본 발명에서 상기 적양파추출물은 다양한 방법을 통해 조성될 수 있으며, 본 발명에서 상기 적양파추출물을 수득하는 방법은 본 발명의 권리범위에 한정하지 않는다. 예를 들어, 상기 적양파추출물은 동결상태인 세절된 적양파를 충분히 가열한 다음, 냉각 후 통상의 압착기 및 여과기로 압착, 여과하여 적양파추출물을 수득할 수 있다. Meanwhile, in the present invention, the red onion extract can be prepared through various methods, and the method for obtaining the red onion extract in the present invention is not limited to the scope of the present invention. For example, the red onion extract can be obtained by sufficiently heating the frozen chopped red onion, cooling it, then pressing and filtering with a conventional press and filter to obtain the red onion extract.
벌꿀은 풍부한 영양과 효능에 의해 어린이, 노인 환자 등 허약 체질의 보양식, 운동 전후 땀 흘린 뒤의 갈증 해소용, 여행자, 운전기사 등의 휴대용 음료 등 널리 보급되고 있다. 본 발명에서 상기 벌꿀은 천연벌꿀 100%를 사용한다. Because of its rich nutrition and efficacy, honey is widely used as a nourishing food for weak constitutions such as children and elderly patients, for quenching thirst after sweating before and after exercise, and as a portable beverage for travelers and drivers. In the present invention, the honey uses 100% natural honey.
죽염은 대나무 통 속에 천일염을 투입한 다음 수차례 고온처리를 반복하여 제조되는 것으로, 위장을 튼튼히 하고, 해독작용이 우수할 뿐 아니라 백혈구를 증가시켜 살균력을 강화시키고, 정혈, 소염, 해열에 탁월하다. 또한, 각종 미네랄이 풍부할 뿐만 아니라, 위염, 위궤양 등 위장병 계통환자에게 총 9195%의 유효 개선율을 구현하며, 위나 장의 점막에 독성 또는 인체손상작용이 없다. 또한, 산성인 종래의 소금, 천일염과 달리 pH 8~13의 알칼리성으로, 산성화된 식단을 중화시키는 효과가 있으며, 염증을 일으키는 물질의 생성을 억제시키는 효과를 구현할 수 있다. 또한, 본 발명에서 상기 죽염은 다양한 약초들에 의한 쓴맛을 제거하는데 도움을 준다. Bamboo salt is manufactured by putting sea salt in a bamboo barrel and then repeating high-temperature treatment several times. . In addition, as well as being rich in various minerals, it realizes an effective improvement rate of 9195% in total for patients with gastrointestinal diseases such as gastritis and gastric ulcer, and there is no toxicity or damage to the human body on the mucous membrane of the stomach or intestines. In addition, unlike conventional salt and sea salt, which are acidic, with an alkalinity of pH 8 to 13, it has an effect of neutralizing an acidified diet, and it is possible to implement an effect of suppressing the production of substances that cause inflammation. In addition, in the present invention, the bamboo salt helps to remove the bitter taste caused by various herbs.
상기 가열 및 교반단계는 상기 추출액을 교반탱크에 넣고 적양파추출물, 벌꿀, 죽염을 첨가한 후 가열/교반하는 방법으로 수행할 수 있다. 구체적으로는 상기 교반탱크 내부에 추출액 1ton에 대하여 적양파추출물 3kg, 벌꿀 2kg, 죽염 50g을 첨가한 다음 80~120℃로 5~7시간 가열 및 교반하는 방법으로 수행할 수 있다. The heating and stirring step may be performed by putting the extract in a stirring tank, adding red onion extract, honey, and bamboo salt, and then heating/stirring. Specifically, it can be carried out by adding 3 kg of red onion extract, 2 kg of honey, and 50 g of bamboo salt to 1 ton of extract in the stirring tank, and then heating and stirring at 80 to 120° C. for 5 to 7 hours.
상기 가열 및 교반단계는 추출액과, 적양파추출물, 벌꿀 및 죽염이 충분히 혼합되면서 숙성되어 잘 어우러지면서 조화로운 맛과 향을 얻음으로써 소비자의 기호도를 향상시키기 위한 공정이다. 따라서, 과도한 열과의 접촉에 의해 오히려 기호도가 감소되지 않도록 상술한 온도와 시간으로 조절하는 것이 바람직하다. The heating and stirring step is a process for improving consumer preference by mixing the extract, red onion extract, honey, and bamboo salt sufficiently to mature and harmonize well, thereby obtaining a harmonious taste and aroma. Therefore, it is preferable to adjust the above-mentioned temperature and time so that the preference is not rather reduced by contact with excessive heat.
한편, 본 발명에서 상기 산양삼, 마늘, 대추 및 적양파는 법제액상유황 및 세리사이트를 시비하여 재배된 것을 사용할 수 있다. On the other hand, in the present invention, the wild ginseng, garlic, jujube and red onion can be used grown by fertilizing legal liquid sulfur and sericite.
여기에서, 법제액상유황이라 함은 유황의 독성 및 자극성을 낮춘 액상의 유황함유 조성물을 의미한다. Here, the legal liquid sulfur means a liquid sulfur-containing composition with lower toxicity and irritation of sulfur.
유황(硫黃, sulfur)은 칼슘, 인, 칼륨 다음으로 인체에 4번째로 많은 미네랄로, 체내의 모든 세포에서 발견되며, 중요 아미노산인 시스틴(cystine), 시스테인(cysteine), 메티오닌(methionine)의 구성성분으로서 세포 자신의 생명을 위해 필수적이다. 또한 비타민인 티아민과 비오틴의 구성성분이며, 타액과 담즙 그리고 호르몬인 인슐린 속에서도 존재한다. 또한, 체중의 약 0.2%를 차지하며, 체내의 광물질 함량의 10%를 황이 차지한다. 이렇듯 유황은 생물의 호흡, 동화 작용 등 신진대사 활동에 없어서는 안 될 가장 중요한 물질 중 하나이다. 그런데, 광물질의 무기유황(Inorganic Sulfur)이나 합성유기유황은 열독성(熱毒性)이 강해서 사람이 직접 섭취할 경우에 생명에 지장을 줄 정도로 강한 독성을 나타낸다.Sulfur is the fourth most abundant mineral in the human body after calcium, phosphorus, and potassium. As a component, it is essential for the life of the cell itself. It is also a component of vitamins thiamine and biotin, and is also present in saliva, bile, and the hormone insulin. In addition, it accounts for about 0.2% of the body weight, and sulfur accounts for 10% of the mineral content in the body. As such, sulfur is one of the most important substances indispensable for metabolic activities such as respiration and assimilation of living things. However, inorganic sulfur or synthetic organic sulfur of minerals has strong thermal toxicity and, when directly ingested by a person, is toxic enough to impair life.
법제(法製)라 함은 자연에서 채취한 원생물질을 독성이 없는 기능성 물질로 처리하는 과정을 의미하는 것으로, 한방에서는 자연 상태의 식물이나 동물, 광물 등을 인체에 해가 없도록 사용하기 위해 처리하는 과정을 의미한다. Beopje (法製) refers to the process of processing protozoan materials collected from nature into non-toxic functional substances. means process.
다음으로, 세리사이트는 견운모라고도 불리며 층상구조의 수화된 알루미늄 규산염 광물군의 일종으로서, 규산질, 칼륨, 칼슘, 나트륨을 함유하며, 원적외선 방사율, 탈취율, 항균 및 항곰팡이성, 음이온 방출, 방오, 대기정화 등의 기능이 우수한 광물이다. Next, sericite, also called sericite, is a kind of hydrated aluminum silicate mineral group with a layered structure. It is a mineral with excellent functions such as purification.
세리사이트의 주성분인 규산질은 토양에서 서서히 분해되면서 비료성분을 보충해 주는 지효성으로써, 흙속의 약한 산이나 작물의 뿌리에서 나오는 산에 조금씩 녹아 효과를 나타내는 가용성이어서 건강하고 안전한 흙 만들기에 가장 적합한 비료이다. 즉, 규산질은 토양개량에 우수한 효과를 제공한다. 또한, 규산 성분이 식물체 내에 흡수되어 세포벽에 규산층을 형성하여 세포를 강화함으로써 병충해에 대한 저항력을 높여주며, 내병성 증대로 세균성 병해, 바이러스성 병해는 물론 냉해에 대한 저항성까지 높여준다. 뿐만 아니라, 생장촉진은 물론 토양개량과 비료효과를 조절하여 질소과잉과 인산흡수 장해 등을 막아주고, 식물체의 신선도를 유지시켜 저장성을 높여주며 과일 등의 당도를 크게 높여주는 효과가 있다.Silicate, the main component of sericite, is a long-acting fertilizer that replenishes fertilizer components as it slowly decomposes in the soil. . That is, siliceous material provides an excellent effect on soil improvement. In addition, the silicic acid component is absorbed into the plant and forms a silicic acid layer on the cell wall to strengthen the cells, thereby increasing the resistance to pests and diseases. In addition, it has the effect of not only promoting growth, but also controlling the soil improvement and fertilizer effect to prevent nitrogen excess and phosphoric acid absorption disorders, maintain the freshness of plants, improve storage, and greatly increase the sugar content of fruits and the like.
칼륨은 질소비료·인산비료와 함께 식물의 생육을 좌우하는 중요성분으로서, 광합성이나 아미노산으로부터의 단백질 합성에 필요하며, 식물의 생리작용을 돕고 조직을 튼튼하게 하는 역할을 한다. 칼륨이 부족하면 생육이 부진하고 잎의 색깔이 짙어지며, 심할 경우 잎에 갈색 반점이 생기고 잎 끝이 붉게 되며 가뭄이나 병충해에도 취약해진다.Potassium, along with nitrogen fertilizers and phosphate fertilizers, is an important element that influences plant growth. If potassium is insufficient, growth is sluggish and the color of the leaves is dark.
칼슘은 16가지 식물 필수 영양소 중 질소, 인, 칼륨에 이어 네 번째로 많이 필요한 성분으로서, 칼슘이 충분해야 식물의 세포막이 튼튼하게 형성되어 좋은 색깔을 지닌 단단한 품질의 농작물을 수확할 수 있다. 또한, 산성토양을 중화하여 중금속의 흡수를 억제하고 유기물의 분해를 촉진하여 토양의 화학성을 개선하며 미생물의 활동을 조장하여 토양구조를 개량하는데, 칼슘이 부족하면 생육저해를 받아 잎 크기가 작아지고 줄기가 가늘어지는 등 여러 가지 생리장해가 발생한다. 토양 내에서 염류 집적이 심하고 비료의 양이온 수준이 높아지면 칼슘 흡수가 잘 안되며, 건조하고 햇빛이 강할수록 작물에 칼슘부족이 일어나기 쉬우므로, 이럴 경우 흡수가 잘 되는 칼슘비료의 살포는 매우 중요하다.Calcium is the fourth most necessary element after nitrogen, phosphorus, and potassium among 16 essential nutrients for plants. When calcium is sufficient, plant cell membranes are formed strong and crops with good color can be harvested. In addition, it neutralizes acidic soil to suppress the absorption of heavy metals, promotes the decomposition of organic matter, improves soil chemistry, and promotes microbial activity to improve soil structure. Various physiological disorders, such as thinning of the stem, occur. If the salt accumulation in the soil is severe and the cation level of the fertilizer is high, calcium absorption is not good, and the dry and the stronger the sunlight, the easier the calcium deficiency in the crop.
나트륨은 질소, 인, 칼륨 등 9대 다량원소와 철, 망간, 붕소 등 7대 미량원소와 더불어 규소, 알루미늄, 니켈, 코발트, 바나듐 등 6원소와 함께 작물 생육에 필요한 필수원소로 분류되고 있으며, 미량원소와 같이 많은 양이 필요하지는 않다.Sodium is classified as an essential element for crop growth along with the 9 major elements such as nitrogen, phosphorus, and potassium, the 7 trace elements such as iron, manganese, and boron, and 6 elements such as silicon, aluminum, nickel, cobalt, and vanadium. It is not required in large quantities like trace elements.
이러한 세리사이트는 적열로 섭씨 700℃내외로 소성하여 제조된 파우더를 사용하며, 산양삼, 마늘, 대추 및 적양파가 재비되는 토양에 시비된다. These sericites use a powder produced by calcining at around 700 ° C. with red heat, and are fertilized in the soil where wild ginseng, garlic, jujube and red onion are re-grown.
한편, 상기 법제액상유황 및 세리사이트는 물에 희석하여 시비하며, 그 혼합 비율은 물과 법제액상유황(또는 세리사이트)을 500:1~1,000:1로 희석하는 것이 바람직하다. On the other hand, the legal liquid sulfur and sericite are diluted in water and fertilized, and the mixing ratio is preferably 500:1 to 1,000:1 diluted with water and legal liquid sulfur (or sericite).
예를 들어, 상기 법제액상유황 및 세리사이트는 2주~4주에 1회 시비하되, 물과 법제액상유황을 500:1~1,000:1의 비율로 희석한 법제액상유황 희석액을 대상물에 시비한 후 물과 세티사이트를 500:1~1,000:1의 비율로 혼합한 세리사이트 혼합액을 대상물에 시비할 수 있다. For example, the legal liquid sulfur and sericite are fertilized once every 2 to 4 weeks, but water and legal liquid sulfur diluted in a ratio of 500:1 to 1,000:1 are applied to the object. Afterwards, a sericite mixed solution in which water and ceticite are mixed in a ratio of 500:1 to 1,000:1 can be applied to the object.
또는, 법제액상유황과 세리사이트를 1:1 비율로 혼합하여 조성된 혼합물과 물을 희석하여 대상물에 시비할 수 있으며, 혼합비율은 대상물의 성질, 특성 또는 토양의 상태에 따라 적절하게 조절될 수 있다. Alternatively, it is possible to fertilize the object by diluting the mixture and water prepared by mixing legal liquid sulfur and sericite in a 1:1 ratio, and the mixing ratio can be appropriately adjusted according to the nature, characteristics or soil condition of the object. have.
또한, 시비방법은 엽면시비 또는 관주시비 중 작물의 특성이나 토양의 상태 등에 따라 적절한 방법을 선택할 수 있다. 엽면시비란 액상 비료와 같은 액체를 식물의 잎에 직접 공급하는 시비방법이며, 관주시비는 관주기를 이용하여 토양내부에 수목 영양제 조성물을 공급하는 방법과 혼합된 원액 그대로를 토양에 희석하여 처리하는 시비방법을 말한다. 이러한 시비방법은 이미 공지된 것으로, 이하 자세한 설명은 생략하도록 한다. In addition, as for the fertilization method, an appropriate method may be selected according to the characteristics of crops or soil condition among foliar fertilization or irrigation fertilization. Foliar fertilization is a fertilization method in which a liquid such as liquid fertilizer is directly supplied to the leaves of plants, and irrigation fertilization is a method of supplying a tree nutrient composition to the inside of the soil using a irrigation cycle, and a method of diluting the mixed undiluted solution into the soil and treating it. say how to fertilize This fertilization method is already known, and a detailed description thereof will be omitted below.
다음으로, 본 발명의 다른 실시예에 따른 면역력 증강용 기능성 음료의 제조방법에 대하여 설명하도록 한다. Next, a method for manufacturing a functional beverage for enhancing immunity according to another embodiment of the present invention will be described.
본 발명의 다른 실시예에 따른 면역력 증강용 기능성 음료의 제조방법은 원료준비단계(S1′)와, 원료액 조성단계(S2′)와, 추출액 조성단계(S3′)와, 가열 및 교반단계(S4′)를 포함한다. The method of manufacturing a functional beverage for enhancing immunity according to another embodiment of the present invention includes a raw material preparation step (S1′), a raw material composition step (S2′), an extract liquid composition step (S3′), and a heating and stirring step ( S4').
상기 원료준비단계(S1′)는 인삼, 대추, 삼백초, 음양곽, 곽향, 지구자, 사상자, 백지, 고삼, 계피로 구성되는 원료를 전처리하여 준비하는 단계이다. 여기에서, 상기 대추, 감초, 삼백초, 지구자는 위에서 일실시예에 따른 원료준비단계에서 충분히 설명하였으므로 이하 자세한 설명은 생략하도록 한다. The raw material preparation step (S1') is a step of pre-processing and preparing raw materials consisting of ginseng, jujube, ginseng, yinyanggwak, gwakhyang, jijija, casualty, white paper, old ginseng, and cinnamon. Here, since the jujube, licorice, sagebrush, and earth ruler have been sufficiently described in the raw material preparation step according to an embodiment above, detailed descriptions thereof will be omitted.
먼저, 본 발명에서 인삼은 진생베리 또는 삼꽃 중 하나를 선택하거나 모두를 사용한다. First, in the present invention, ginseng selects one of ginseng berry or ginseng flower, or uses all of them.
인삼의 열매인 진생베리는 약리효능성분인 진세노사이드류를 포함하고 있어 세포재생, 항염증, 중추신경계질환, 항불안, 신경계, 마약중독해독 효능, 혈관작용, 알콜해독, 지질대사와 피로회복, 항당뇨, 고지혈증, 항바이러스, 면역증강, 성기능 개선, 항암 및 암 예방 효능 등을 나타내는 것으로 알려져 있다. Ginseng berry, the fruit of ginseng, contains ginsenosides, which are pharmacologically effective ingredients, so it has cell regeneration, anti-inflammatory, central nervous system disease, anti-anxiety, nervous system, drug addiction detoxification effect, blood vessel action, alcohol detoxification, lipid metabolism and fatigue recovery, It is known to exhibit antidiabetic, hyperlipidemia, antiviral, immune enhancement, sexual function improvement, anticancer and cancer prevention efficacy, and the like.
특히, 진세노사이드 Rb1으로 대표되는 panaxadiol(PD)계 사포닌은 중추신경에 대한 억제작용을 나타내어 정신안정, 신경이완, 진통, 항암, 항경련, 혈압강하 작용 등을 나타내며, 진세노사이드 Rg1으로 대표되는 panaxatriol(PT)계 사포닌은 중추신경에 작용하여 항피로작용을 나타내는 것으로 알려져 있다.In particular, panaxadiol (PD)-based saponins represented by ginsenoside Rb1 have inhibitory effects on the central nervous system, thereby exhibiting mental stability, neuroleptic, analgesic, anticancer, anticonvulsant, and blood pressure lowering effects, and are represented by ginsenoside Rg1. It is known that panaxatriol (PT)-based saponins act on the central nervous system to exhibit anti-fatigue action.
또한, 진생베리에는 진세노사이드 Rg1 1~2중량%, Re 28~40중량%, Rf 1~8중량%, Rb1 6~7중량%, Rg2 5~14중량%, Rc 2~36중량%, Rb2 10~11중량%, Rb3 1~2중량% 및 Rd 16~33중량% 등이 함유되어 있으며, Re와 Rd가 전체 함량 중에서 40 ~ 73중량%까지 포함되어 있어 인삼뿌리에 비해 5배 정도 많이 포함되어 있다.In addition, ginseng berry contains
인삼꽃은 인삼의 지상부에 속하고 진세노사이드 함량이 뿌리보다 많고, 포함되는 진세노사이드의 종류도 뿌리와 유사한 것으로 알려져 있으며, Rb2, Rc, Rd, Re, Rg1 등과 같은 저분자 진세노사이드가 다량 함유되어 있다. Ginseng flower belongs to the above-ground part of ginseng and contains more ginsenosides than roots, and the types of ginsenosides included are also known to be similar to those of roots. is contained.
음양곽은 삼지구엽초라고도 불리며 매자나무과에 속하는 다년생초본식물로서, 이식물의 지상부를 약용으로 사용한다. 강장, 거풍강정, 이뇨 및 신경성 강장제로 귀히 여겨온 동양의학제이다. 음약곽의 주성분 중 프레닐플라보노이드(prenylflavonoid)는 하복부의 혈관을 선택적으로 확장시켜주는 활성이 있는 것으로 알려지고 있다. 또한 이카인(icarin)은 음양곽의 주 약효성분으로 고혈압에 효과를 나타내는 성분으로 보고되고 있으며, 음양곽 추출물은 식균작용의 기능을 항진시키는 효과와 항산화 활성물질도 함유하고 있는 것으로 알려지고 있다Yin-yanggwak, also called Samji-leaf plant, is a herbaceous perennial plant belonging to the barberry family, and the above-ground part of the transplant is used for medicinal purposes. It is an oriental medicine that has been valued as a tonic, geopunggangjeong, diuretic, and nervous tonic. Among the main ingredients of Eumyakgak, prenylflavonoids are known to have the activity of selectively expanding blood vessels in the lower abdomen. In addition, icarin is reported as a component showing an effect on high blood pressure as the main medicinal component of Yin Yang Kwak.
곽향은 꿀풀과에 속하는 배초향의 지상부를 말한다. 토곽향(土藿香), 배초향(排草香)이라 지칭되기도 한다. 상기 곽향은 껍질을 말려서 사용할 수 있으며, 전초, 잎, 꽃, 줄기, 새싹 또는 그 조합일 수 있고, 건조된 전초, 잎, 꽃, 줄기, 새싹 등을 사용할 수 있다. 상기 곽향은 세절된 것을 사용할 수 있다. 소화 장애가 따르는 감기로 가슴이 답답하고 메스꺼운 증상 및 발열, 두통, 구토, 설사에 쓰며 차로 복용시 더위를 덜 느끼도록 하는 효과가 있다.Kwakhyang refers to the above-ground part of baechohyang belonging to the family Lamiaceae. It is also called Togwakhyang (土藿香) and Baechohyang (排草香). The Kwakhyang may be used by drying the bark, and may be an outpost, leaf, flower, stem, sprout, or a combination thereof, and dried outpost, leaf, flower, stem, sprout, etc. may be used. The gwakhyang may be used chopped. It is used for chest pain, nausea, fever, headache, vomiting, and diarrhea caused by a cold with digestive problems.
사상자는 맵고 쓰며 따뜻한 성질이 있고 독이 없다. 항원충작용, 성호르몬 유사작용과 항알레르기 작용 등이 있고, 사상자의 주요성분은 토릴린(torilin), 토릴로론(torilolone) 등의 세스퀴테르펜(sesquiterpene)계 화합물이 함유되어 있다.The casualties are spicy, bitter, warm, and non-poisonous. It has antiprotozoal action, sex hormone-like action and anti-allergic action, and the main component of the casualty is sesquiterpene compounds such as torilin and torilolone.
백지는 달고 매우며 따뜻한 성질이 있고 독이 없다. 미주신경 및 척수부의 흥분작용과 동맥혈류량 증가 등이 있으며 두통에 효과가 있다. 백지의 주요성분은 앵게리코톡신(angelicotoxin), 백-안젤리신(byak-angelicin), 옥시퓨시다린(oxypeucedanin), 백-안젤리콜(byak-angelicol), 임페라토린(imperatorin), 이소임페라토린(isoimperatorin), 베르갑텐(bergapten) 등의 쿠마린(coumarin)계 화합물이 함유되어 있다. White paper is sweet, very, warm, and non-poisonous. It has excitatory action on the vagus nerve and spinal cord and increases arterial blood flow, and is effective for headaches. The main ingredients of white paper are angelicotoxin, byak-angelicin, oxypeucedanin, byak-angelicol, imperatorin, isoimperatorin ( It contains coumarin-based compounds such as isoimperatorin) and bergapten.
고삼은 콩과의 다년생 초본으로서, 알카로이드류(alkaloids)로 마트린(matrine), 옥시마트린(oxymatrine) 등이 있으며, 플라보노이드류(flavonoids)로는 쿠쉐놀 H(kushenol H), 쿠쉐놀 K(kushenol K), 쿠라리놀(kurarinol), 쿠라리딘(kuraridine) 등을 주성분으로 한다. 고삼은 위를 보강하는 건위작용과 대장출혈을 예방, 치료하는 작용 이외에 해열, 이질, 소화불량, 식욕부진에 효과가 있다.Ginseng is a perennial herb in the legume family, and there are matrine and oxymatrine as alkaloids, and kushenol H and kushenol K as flavonoids. K), Kurarinol, Kuraridine, etc. are the main ingredients. Ginseng is effective in antipyretic, dysentery, indigestion, and loss of appetite in addition to the action of reinforcing the stomach and preventing and treating colon bleeding.
다음으로, 상기 원료액 조성단계(S2′)는 상기 전처리를 거쳐 준비된 원료를물에 투입한 다음 가열하여 원료액으로 조성하는 단계이다. Next, the raw material solution composition step (S2 ′) is a step of adding the raw material prepared through the pre-treatment to water and then heating it to form a raw material solution.
바람직하게는 상기 원료액을 조성하는 단계는 물 1.2ton에 대하여 인삼10kg, 대추 20kg, 감초15kg, 삼백초 15kg, 음양곽 5kg, 곽향 5kg, 지구자 5kg, 사상자 5kg, 백지5kg, 고삼 5kg 및 계피 15kg가 투입되며, 80~120℃로 5~7시간 가열하여 원료액을 조성한다. 각 원료가 함량비 미만으로 첨가되면 함량미달로 인해 원료로부터 제공되는 효과를 기대하기 어려우므로 바람직하지 않다. Preferably, the step of composing the raw material solution comprises 10 kg of ginseng, 20 kg of jujube, 15 kg of licorice, 15 kg of ginseng, 5 kg of eumyanggwak, 5kg of gwakhyang, 5 kg of ginseng, 5 kg of casualties, 5 kg of white paper, 5 kg of white paper, 5 kg of old ginseng and 15 kg of cinnamon with respect to 1.2 tons of water. It is added and heated at 80~120℃ for 5~7 hours to form a raw material solution. When each raw material is added in less than the content ratio, it is not preferable because it is difficult to expect the effect provided from the raw material due to the insufficient content.
다음으로, 상기 추출액 조성단계(S3′)는 상기 원료액에 전처리된 마늘을 첨가한 다음 가열한 후 압착하여 추출액을 조성하는 단계이다. Next, the extract solution composition step (S3 ′) is a step of adding pre-treated garlic to the raw material solution, heating it, and then compressing it to form an extract solution.
원료액에 첨가되는 마늘은 강정, 강장, 체력증강, 인체기능과 세포의 화력 증진, 동맥경화, 고혈압, 콜레스테톨 제거, 항암 작용 등 다양한 작용을 한다.Garlic added to the raw material has various actions such as strengthening, tonicity, physical strength enhancement, human body function and cell thermal power enhancement, arteriosclerosis, high blood pressure, cholesterol removal, and anticancer action.
바람직하게는, 상기 원료액 1ton에 대하여 마늘 20kg이 첨가되며, 마늘 첨가 후 60~70℃로 10~15시간 가열한 후 압착하여 추출액을 조성한다. Preferably, 20 kg of garlic is added to 1 ton of the raw material solution, and after adding garlic, it is heated at 60 to 70° C. for 10 to 15 hours and then compressed to form an extract.
다음으로, 상기 가열 및 교반단계(S4′)는 상기 추출액에 함유된 이물질, 고형물 등을 여과한 다음 적양파추출물과 벌꿀, 강황소금을 첨가한 후 교반탱크에서 가열 및 교반하는 단계로서, 구체적으로는 교반탱크 내부에 추출액 1ton에 대하여 적양파추출물 3kg, 벌꿀 2kg, 강황소금 50g을 첨가한 다음 80~120℃로 5~7시간 가열 및 교반하는 방법으로 수행할 수 있다. Next, the heating and stirring step (S4 ′) is a step of filtering foreign substances and solids contained in the extract, then adding red onion extract, honey, and turmeric salt, and then heating and stirring in a stirring tank. Specifically, can be carried out by adding 3 kg of red onion extract, 2 kg of honey, and 50 g of turmeric salt to 1 ton of extract in a stirring tank, and then heating and stirring at 80 to 120 ° C for 5 to 7 hours.
여기에서, 강황소금은 강황소금이 함유된 소금을 지칭한다. Here, turmeric salt refers to salt containing turmeric salt.
강황(薑黃)은 생강과에 속하는 다년생 숙근(宿根)초본인 커쿠마 롱가 엘의 뿌리를 건조한 것으로, 예로부터 간질환, 우울증 등 각종 질환을 예방하는데 사용되었다. 식용과 약용을 겸하는 좋은 재료이다. 강황의 노란색 성분인 커큐민은 페놀화합물로서 강황 중량의 2-6%정도 차지하며 심장마비 예방에 도움과 당뇨의 발병을 지연시킨다는 연구결과가 있다. 이외에도 암, 치매예방, 관절통증 완화, 혈액순환 원활, 동맥경화 예방, 어혈관리 등에 효능이 있다고 한다. 이는 커큐민의 강력한 항산화 효능에 의한 것으로 알려져 있다.Turmeric (薑黃) is the dried root of curcuma longa el, a perennial succulent plant belonging to the ginger family, and has been used to prevent various diseases such as liver disease and depression since ancient times. It is a good ingredient for both food and medicine. Curcumin, a yellow component of turmeric, is a phenolic compound, accounting for 2-6% of the weight of turmeric, and studies have shown that it helps prevent heart attacks and delays the onset of diabetes. In addition, it is said to be effective in preventing cancer, dementia, relieving joint pain, smoothing blood circulation, preventing arteriosclerosis, and relieving fish blood vessels. This is known to be due to the strong antioxidant effect of curcumin.
강황소금은 이미 공지된 것을 사용할 수 있으며, 그 제조방법은 본 발명의 권리범위에 한정하지 않는다. A well-known turmeric salt can be used, and the manufacturing method is not limited to the scope of the present invention.
상기 가열 및 교반단계는 추출액과, 적양파추출물, 벌꿀 및 강황소금이 충분히 혼합되면서 숙성되어 잘 어우러지면서 조화로운 맛과 향을 얻음으로써 소비자의 기호도를 향상시키기 위한 공정이다. 따라서, 과도한 열과의 접촉에 의해 오히려 기호도가 감소되지 않도록 상술한 온도와 시간으로 조절하는 것이 바람직하다. The heating and stirring step is a process for improving consumer preference by thoroughly mixing the extract, red onion extract, honey, and turmeric salt, maturing, and obtaining a harmonious taste and aroma. Therefore, it is preferable to adjust the above-mentioned temperature and time so that the preference is not rather reduced by contact with excessive heat.
본 발명의 다른 실시예에 따른 면역력 증강용 기능성 음료의 제조방법 또한 산양삼, 마늘, 대추 및 적양파는 법제액상유황 및 세리사이트를 시비하여 재배된 것을 사용하는 것이 바람직하다. In addition, it is preferable to use wild ginseng, garlic, jujube and red onion grown by fertilizing legal liquid sulfur and sericite.
또한, 상기 법제액상유황 및 세리사이트는 물에 희석하여 시비하되 그 혼합비율이나 시비방법은 상술한 바와 동일하게 이루어진다. In addition, the legal liquid sulfur and sericite are diluted in water and fertilized, but the mixing ratio and fertilization method are the same as described above.
도 2a)는 일반 산양삼의 진세노이드 함량과 고형분 함량을 측정한 시험성적서이고, 도 2b)는 본 발명의 실시예에 따라 법제액상유황 및 세리사이트를 시비하여 재배한 산양삼의 진세노이드 함량과 고형분 함량을 측정한 시험성적서이다. 도 2a)와 같이 일반 산양삼의 경우 진세노이드 함량이 0.47mg/g이고, 고형분은 45.75%인데 반하여, 2b)와 같이 본 발명의 실시예에 따른 산양삼은 진세노이드 함량이 1.58mg/g로서 3배 이상 증가하였으며, 고형분은 검출되지 않았다. Figure 2a) is a test report measuring the ginsenoid content and solid content of general wild ginseng, and Figure 2b) is the ginsenoid content and solid content of wild ginseng grown by fertilizing legal liquid sulfur and sericite according to an embodiment of the present invention is a test report that measures As shown in FIG. 2a), in the case of general wild ginseng, the ginsenoid content is 0.47 mg/g and the solid content is 45.75%, whereas, as in 2b), the wild ginseng according to the embodiment of the present invention has a ginsenoid content of 1.58 mg/g, which is three times It increased abnormally, and solid content was not detected.
상기와 같이 본 발명은 산양삼, 마늘, 대추 및 적양파에 법제액상유황 및 세리사이트를 시비하여 재배함으로써 작물에 충분한 유황성분을 공급할 수 있고, 이를 통해 열매 또는 결실부에 질소, 인산, 유황 및 인과 칼륨 성분의 영양분이 많이 집적되어 양질의 작물을 재배할 수 있다. 특히, 산양삼의 경우 법제액상유황 및 세리사이트를 시비하지 않은 대조구에 비해 진세노사이드의 함량이 10~27배 증폭되며, 마늘과 적양파의 경우 시스틴, 알리신 성분이 대조구 대비 4배 이상 증폭되는 효과가 있다. As described above, the present invention can supply sufficient sulfur components to crops by fertilizing and cultivating wild ginseng, garlic, jujube and red onion with legal liquid sulfur and sericite, and through this, nitrogen, phosphoric acid, sulfur and phosphorus in the fruit or fruiting part High-quality crops can be grown because a lot of nutrients from potassium are accumulated. In particular, in the case of wild ginseng, the content of ginsenoside is amplified 10 to 27 times compared to the control that is not fertilized with legal liquid sulfur and sericite, and in the case of garlic and red onion, the cystine and allicin components are amplified 4 times or more compared to the control. there is
따라서, 이러한 과정을 거쳐 재배되는 원료로부터 조성되는 본 발명에 따른 면역력 증강용 기능성 음료는 우수한 항바이러스 기능을 제공할 수 있다. Therefore, the functional beverage for enhancing immunity according to the present invention, which is prepared from raw materials grown through this process, can provide excellent antiviral function.
한편, 도면에는 도시하지 않았으나, 본 발명에 따른 면역력 증강용 기능성 음료의 제조방법은 추가로 음료의 제조과정에서 포함된 불순물을 제거하는 공정, 파우치나 용기에 충진하는 공정, 멸균 후 처리하는 공정 등을 포함할 수 있다.On the other hand, although not shown in the drawings, the method for manufacturing a functional beverage for enhancing immunity according to the present invention is a process of additionally removing impurities included in the manufacturing process of the beverage, filling a pouch or container, sterilizing, etc. may include
실시예 1.Example 1.
산양삼, 대추, 육두구, 감초, 삼백초, 창출, 백출, 지구자, 익모초, 황기, 계피로 구성되는 원료를 선별한 후 세척하여 준비하였다. Raw materials consisting of wild ginseng, jujube, nutmeg, licorice, ginseng, chrysanthemum, baekchul, guja, motherwort, astragalus and cinnamon were selected, washed and prepared.
물 1.2ton에 대하여 산양삼 10kg, 대추 20kg, 육두구 10kg, 감초 10kg, 삼백초 10kg, 창출 5kg, 백출 5kg, 지구자 10kg, 익모초 5kg, 황기 20kg 및 계피 10kg를 투입한 다음 100℃로 6시간 가열하여 원료액을 조성하였다. For 1.2 tons of water, 10 kg of wild ginseng, 20 kg of jujube, 10 kg of nutmeg, 10 kg of licorice, 10 kg of ginseng vinegar, 5 kg of ginseng, 5 kg of baekchul, 10 kg of earthworm, 5 kg of motherwort herb, 20 kg of astragalus and 10 kg of cinnamon, and heating at 100°C for 6 hours liquid was prepared.
다음으로, 상기 원료액 1ton에 대하여 마늘 10kg을 첨가한 다음 65℃ 12시간 가열한 후 압착기를 통해 압착하여 추출액을 조성하였다. Next, 10 kg of garlic was added to 1 ton of the raw material solution, heated at 65° C. for 12 hours, and then compressed through a press to prepare an extract.
다음으로, 상기 추출액을 여과한 후 추출액 1ton에 대하여 적양파추출물 3kg, 천연벌꿀 2kg, 죽염 50g을 첨가한 후 교반탱크에서 90℃로 6시간 가열 및 교반하여 본 발명의 일실시예에 따른 면역력 증강용 기능성 음료를 조성하였다. Next, after filtering the extract, 3 kg of red onion extract, 2 kg of natural honey, and 50 g of bamboo salt are added to 1 ton of extract, and then heated and stirred at 90° C. in a stirred tank for 6 hours to enhance immunity according to an embodiment of the present invention A functional beverage was formulated for use.
여기에서, 산양삼, 마늘, 대추는 법제액상유황 및 세리사이트를 시비하여 재배한 것을 사용하였으며, 적양파추출물은 법제액상유황 및 세리사이트를 시비하여 재배된 것으로부터 추출하여 수득하였다.Here, wild ginseng, garlic, and jujube were grown by fertilizing legal liquid sulfur and sericite, and red onion extract was obtained by extracting from those cultivated by fertilizing legal liquid sulfur and sericite.
실시예 2.Example 2.
인삼, 대추, 감초, 삼백초, 음양곽, 곽향, 지구자, 사상자, 백지, 고삼, 계피로 구성되는 원료를 선별한 후 세척하여 준비하였다. Raw materials consisting of ginseng, jujube, licorice, sambaekcho, yinyanggwak, gwakhyang, gujija, saengjae, white paper, old ginseng, and cinnamon were selected, washed and prepared.
물 1.2ton에 대하여 인삼10kg, 대추 20kg, 감초15kg, 삼백초 15kg, 음양곽 5kg, 곽향 5kg, 지구자 5kg, 사상자 5kg, 백지5kg, 고삼 5kg 및 계피 15kg를 투입한 다음 95℃로 7시간 가열하여 원료액을 조성하였다. To 1.2 tons of water, 10 kg of ginseng, 20 kg of jujube, 15 kg of licorice, 15 kg of white vinegar, 5 kg of yin and yang, 5 kg of gwakhyang, 5 kg of earthworm, 5 kg of casualties, 5 kg of white paper, 5 kg of old ginseng and 15 kg of cinnamon were added, and then heated at 95°C for 7 hours. liquid was prepared.
다음으로, 상기 원료액 1ton에 대하여 마늘 20kg을 첨가한 다음 70℃ 10시간 가열한 후 압착기를 통해 압착하여 추출액을 조성하였다. Next, 20 kg of garlic was added to 1 ton of the raw material solution, heated at 70° C. for 10 hours, and compressed through a press to prepare an extract.
다음으로, 상기 추출액을 여과한 후 추출액 1ton에 대하여 적양파추출물 3kg, 천연벌꿀 2kg, 강황소금 50g을 첨가한 후 교반탱크에서 100℃로 5시간 가열 및 교반하여 본 발명의 다른실시예에 따른 면역력 증강용 기능성 음료를 조성하였다. Next, after filtering the extract, 3 kg of red onion extract, 2 kg of natural honey, and 50 g of turmeric salt are added to 1 ton of the extract, and then heated and stirred at 100° C. for 5 hours in a stirred tank for immunity according to another embodiment of the present invention A functional beverage for enhancement was prepared.
Claims (5)
상기 원료를 물에 투입한 다음 80~120℃로 5~7시간 가열하여 원료액을 조성하는 단계와;
상기 원료액에 전처리된 마늘을 첨가한 다음 60~70℃ 10~15시간 가열한 후 압착하여 추출액을 조성하는 단계와;
상기 추출액을 여과한 후 적양파추출물과 벌꿀, 죽염을 첨가한 후 교반탱크에서 80~120℃로 5~7시간 가열 및 교반하는 단계;
를 포함하는 것을 특징으로 하는 면역력 증강을 위한 기능성 음료의 제조방법.
Wild ginseng, jujube, nutmeg, licorice, ginseng, chrysanthemum, baekchul, guja, motherwort, astragalus, and cinnamon;
preparing a raw material solution by adding the raw material to water and then heating it at 80 to 120° C. for 5 to 7 hours;
preparing an extract by adding pre-treated garlic to the raw material solution and then heating at 60 to 70° C. for 10 to 15 hours;
After filtering the extract, adding red onion extract, honey, and bamboo salt, heating and stirring at 80 to 120° C. for 5 to 7 hours in a stirring tank;
A method of manufacturing a functional beverage for enhancing immunity, comprising:
상기 원료액을 조성하는 단계는 물 1.2ton에 대하여 산양삼 10kg, 대추 20kg, 육두구 10kg, 감초 10kg, 삼백초 10kg, 창출 5kg, 백출 5kg, 지구자 10kg, 익모초 5kg, 황기 20kg 및 계피 10kg가 투입되고,
상기 추출액을 조성하는 단계는 원료액 1ton에 대하여 마늘 10kg이 첨가되며,
상기 가열 및 교반단계는 추출액 1ton에 대하여 적양파추출물 3kg, 벌꿀 2kg, 죽염 50g이 첨가되는 것을 특징으로 하는 면역력 증강을 위한 기능성 음료의 제조방법.
The method of claim 1,
In the step of composing the raw material solution, 10 kg of wild ginseng, 20 kg of jujube, 10 kg of nutmeg, 10 kg of licorice, 10 kg of ginseng, 5 kg of creation, 5 kg of baekchul, 10 kg of earthworm, 5 kg of motherwort, 20 kg of astragalus and 10 kg of cinnamon are input with respect to 1.2 tons of water,
In the step of composing the extract, 10 kg of garlic is added to 1 ton of the raw material solution,
In the heating and stirring step, 3 kg of red onion extract, 2 kg of honey, and 50 g of bamboo salt are added to 1 ton of extract.
상기 원료를 물에 투입한 다음 80~120℃로 5~7시간 가열하여 원료액을 조성하는 단계와;
상기 원료액에 전처리된 마늘을 첨가한 다음 60~70℃ 10~15시간 가열한 후 압착하여 추출액을 조성하는 단계와;
상기 추출액을 여과한 후 적양파추출물과 벌꿀, 강황소금을 첨가한 후 교반탱크에서 80~120℃로 5~7시간 가열 및 교반하는 단계;
를 포함하는 것을 특징으로 하는 면역력 증강을 위한 기능성 음료의 제조방법.
A step of pre-treating and preparing raw materials consisting of ginseng, jujube, licorice, ginseng, yinyanggwak, gwakhyang, gujija, saengsaeng, white paper, ginseng, and cinnamon;
preparing a raw material solution by adding the raw material to water and then heating it at 80 to 120° C. for 5 to 7 hours;
preparing an extract by adding pre-treated garlic to the raw material solution and then heating at 60 to 70° C. for 10 to 15 hours;
After filtering the extract, adding red onion extract, honey, and turmeric salt, heating and stirring at 80 to 120° C. for 5 to 7 hours in a stirring tank;
A method of manufacturing a functional beverage for enhancing immunity, comprising:
상기 원료액을 조성하는 단계는 물 1.2ton에 대하여 인삼10kg, 대추 20kg, 감초15kg, 삼백초 15kg, 음양곽 5kg, 곽향 5kg, 지구자 5kg, 사상자 5kg, 백지5kg, 고삼 5kg 및 계피 15kg가 투입되고,
상기 추출액을 조성하는 단계는 원료액 1ton에 대하여 마늘 20kg이 첨가되며,
상기 가열 및 교반단계는 추출액 1ton에 대하여 적양파추출물 3kg, 벌꿀 2kg, 강황소금 50g이 첨가되는 것을 특징으로 하는 면역력 증강을 위한 기능성 음료의 제조방법.
4. The method of claim 3,
In the step of composing the raw material solution, 10 kg of ginseng, 20 kg of jujube, 15 kg of licorice, 15 kg of ginseng, 5 kg of ginseng, 5 kg of gwakhyang, 5 kg of ginseng, 5 kg of casualties, 5 kg of white paper, 5 kg of old ginseng and 15 kg of cinnamon are input with respect to 1.2 tons of water,
In the step of composing the extract, 20 kg of garlic is added to 1 ton of the raw material solution,
In the heating and stirring step, 3 kg of red onion extract, 2 kg of honey, and 50 g of turmeric salt are added to 1 ton of extract.
상기 산양삼, 인삼, 마늘, 대추는 법제액상유황 및 세리사이트를 시비하여 재배된 것이며,
상기 적양파추출물은 법제액상유황 및 세리사이트를 시비하여 재배된 적양파로부터 추출된 것을 특징으로 하는 면역력 증강을 위한 기능성 음료의 제조방법.
5. The method according to any one of claims 1 to 4,
The wild ginseng, ginseng, garlic, and jujube are cultivated by fertilizing legal liquid sulfur and sericite,
The red onion extract is a method of manufacturing a functional beverage for enhancing immunity, characterized in that it is extracted from red onions grown by fertilizing legal liquid sulfur and sericite.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200164287A KR102540747B1 (en) | 2020-11-30 | 2020-11-30 | Manufacturing method of drink |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200164287A KR102540747B1 (en) | 2020-11-30 | 2020-11-30 | Manufacturing method of drink |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220076562A true KR20220076562A (en) | 2022-06-08 |
KR102540747B1 KR102540747B1 (en) | 2023-06-08 |
Family
ID=81981021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200164287A Active KR102540747B1 (en) | 2020-11-30 | 2020-11-30 | Manufacturing method of drink |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102540747B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102687711B1 (en) * | 2023-12-21 | 2024-07-22 | 조성순 | Manufacturing method of marsh snails extracts comprising cultivated wild ginseng and epimedium koreanum |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140049673A (en) * | 2012-10-18 | 2014-04-28 | 반계선 | Manufacturing method of the enzyme using 125 kinds of medicinal herb extracts (extract using extract by the co2 (or n2) carrier gas method, enzyme extract by the fermentation method, microwave and filter) |
KR20160130636A (en) * | 2015-05-04 | 2016-11-14 | (주)한의바이오 | Methods for preparing plant extract |
KR101682440B1 (en) * | 2016-02-23 | 2016-12-05 | 박종구 | Liquid Type Sulfur Fertilizer and Manufacturing Method Thereof |
KR20170114403A (en) * | 2016-04-04 | 2017-10-16 | 함양군 | Beverage composition with the extract of aged onion and the concentrate of wild genseng fruit |
KR20200116076A (en) | 2017-10-16 | 2020-10-08 | 센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. | Lentiviral vectors for PKLR delivery to treat pyruvate kinase deficiency |
-
2020
- 2020-11-30 KR KR1020200164287A patent/KR102540747B1/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140049673A (en) * | 2012-10-18 | 2014-04-28 | 반계선 | Manufacturing method of the enzyme using 125 kinds of medicinal herb extracts (extract using extract by the co2 (or n2) carrier gas method, enzyme extract by the fermentation method, microwave and filter) |
KR20160130636A (en) * | 2015-05-04 | 2016-11-14 | (주)한의바이오 | Methods for preparing plant extract |
KR101682440B1 (en) * | 2016-02-23 | 2016-12-05 | 박종구 | Liquid Type Sulfur Fertilizer and Manufacturing Method Thereof |
KR20170114403A (en) * | 2016-04-04 | 2017-10-16 | 함양군 | Beverage composition with the extract of aged onion and the concentrate of wild genseng fruit |
KR20200116076A (en) | 2017-10-16 | 2020-10-08 | 센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. | Lentiviral vectors for PKLR delivery to treat pyruvate kinase deficiency |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102687711B1 (en) * | 2023-12-21 | 2024-07-22 | 조성순 | Manufacturing method of marsh snails extracts comprising cultivated wild ginseng and epimedium koreanum |
Also Published As
Publication number | Publication date |
---|---|
KR102540747B1 (en) | 2023-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101176590B1 (en) | Herbal Composition for Removing Hangover and Beverage Containing the Same | |
CN103169119B (en) | Pure natural plant beverage and preparation method thereof | |
CN104856009A (en) | An eucommia ulmoides staminate flower health-care product | |
KR100939906B1 (en) | Feed Additives for Fish Farming Using Herbal Extracts | |
KR101060309B1 (en) | Jujube | |
KR20150040392A (en) | undiluted stevia liquid and the berages, and its manufacturing method | |
KR102540747B1 (en) | Manufacturing method of drink | |
CN105767370A (en) | Herbal tea beverage prepared from vine tea, preparation method and application of beverage | |
CN105432924A (en) | Selenium-rich candy and preparation method thereof | |
KR101338560B1 (en) | Method for manufacturing a health noodles oriental medicine composition and mulberry is contained | |
CN104799047A (en) | Chinese herbal medicine phagostimulant for Truogx sinensis and preparation method thereof | |
KR100780552B1 (en) | Functional milk powder for infants and young children, including herbal medicines and manufacturing method thereof | |
CN104798950A (en) | Immune kungfu tea and preparation method thereof | |
CN105558838A (en) | Multi-flavor black beans and preparation method thereof | |
KR101028073B1 (en) | A composition and method for producing a composition having the action and mechanism for improving blood circulation, activating each part of the body and enhancing immunity | |
KR20200103995A (en) | Pills for health supplements and methods for manufacturing same | |
CN104430720A (en) | Method for making functional biscuits through okra, fungus and algae plant mixtures | |
KR20170002050A (en) | The natural brewing vinegarmade containing effective ingredient of mud and its producing method | |
KR20050080501A (en) | A making method of health assistance food for high blood pressure, fatness, diabetes patients. | |
KR20030070948A (en) | noodle food manufacturing method for resuming one's spirits and an a product thererof | |
CN104383209A (en) | Wine for tonifying spleen and harmonizing stomach and preparation method | |
CN104799007A (en) | Chinese herbal medicine additive for enhancing disease resistance of Truogx sinensis and preparation method thereof | |
KR20030079289A (en) | The carbonated soft drinks a manufacturing process and a composition of ling indigestion hangover cures. | |
CN104473072A (en) | Punica granatum-flavored zingiber officinale roscoe crystal particles and preparation method thereof | |
CN110437008A (en) | A kind of pure Chinese medicine Biological water soluble fertilizer and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20201130 |
|
PA0201 | Request for examination | ||
PN2301 | Change of applicant |
Patent event date: 20210201 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20221118 Patent event code: PE09021S01D |
|
E90F | Notification of reason for final refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20230521 Patent event code: PE09021S02D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230531 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20230601 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20230601 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |